United Imaging (688271) Stock Price, Fundamentals & Analysis

What 688271 does

United Imaging (688271) is a Healthcare stock in the Medical Devices industry listed on the Shanghai Stock Exchange. Headquartered in Shanghai, China, the company develops and produces advanced medical imaging solutions, radiotherapy equipment, life science instruments, and intelligent digital solutions worldwide. Its portfolio includes molecular imaging products, magnetic resonance imaging systems, computed tomography and digital radiography equipment, mammography and angiography devices, mobile C-arm equipment, and radiotherapy systems such as the uRT-linac 506c, uRT-linac 306, and Intelligent RT Cloud Ecosystem. The company also offers uVision, a remote vision system for real-time positioning observation, a low-dose 3D mammography platform, and the Remote Vision and Exposure Control handheld X-ray technology. In addition, United Imaging provides United Neuro, software for analyzing functional magnetic resonance imaging and diffusion tensor imaging data, and U-VIEWER, software for viewing DICOM images.

Key numbers explained

• The current price is 102,41 CNY, reflecting the latest trading value of one share.
• The trailing P/E ratio of 47,2 compares the price to the last 12 months of earnings, while the forward P/E ratio of 29,2 uses expected future earnings, offering a sense of how the market prices growth.
• The dividend yield of 0,25% shows the annual dividend relative to the share price; the ex-dividend date is 9 sept. 2026, and only 10% of earnings are paid out as dividends.
• Beta of 0,28 suggests the stock tends to move less than the overall market, indicating lower volatility.
• The 52-week range of 95,9 – 159,06 CNY and the -30,8% price change over the last 52 weeks illustrate recent price movement.
• Revenue, trailing 12 months: 14,84 mld. CNY, with a year-over-year growth of 17,1%, while the profit margin is 11,9% and the operating margin is 13,2%.
• The return on equity of 8,2% measures how effectively the company generates profit from shareholders' equity.
• The debt-to-equity ratio of 8,2% indicates a conservative capital structure with limited reliance on debt.

What to watch

Investors tracking United Imaging may consider the broader Healthcare sector and the Medical Devices industry, where regulatory approvals, technological innovation, and global demand for imaging equipment play a role. As a component of the CSI 300, the stock is exposed to large-cap Chinese market dynamics. Within the Shanghai Stock Exchange ecosystem, peers such as Fosun Pharmaceutical (600196), Shanghai Pharmaceuticals Holding (601607), and WuXi AppTec (603259) operate in related segments, and movements in these names can influence sector sentiment. General factors such as R&D pipelines, international expansion, and policy shifts in healthcare funding are relevant to monitor.